Business Wire

Seoul Viosys and SETi’s Violeds Technology Proves 99.9% Sterilization of Coronavirus (COVID-19) in 30 Seconds 

Share

Seoul Viosys (KOSDAQ: 092190) and Sensor Electronic Technology, Inc. (“SETi”), leading global innovators of UV LED products and technology, announced that it has been successful in achieving 99.9% sterilization of coronavirus (COVID-19) in 30 seconds. Tests were conducted with the research group of Korea University, Korea’s top rank university, by using a compound semiconductor Violeds technology that is being mass-produced.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200402005348/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Fig 1. COVID-19 after sterilized by Violeds (Graphic: Business Wire)

As COVID-19 spread throughout the world, SETi and Seoul Viosys, the fourth-largest global LED maker of Seoul Semiconductor’s affiliates, devoted resources to show how Violeds technology can directly sterilize the virus. The goal has always been to provide technology for a cleaner world, and this includes minimizing the spread of COVID-19, while the company will quickly offer strong sterilization solutions for coronavirus in air as well as surface of goods such as facial masks and smartphones.

In the study by SETi and Seoul Viosys, Violeds technology is used to show just how strong the sterilization effect can be on COVID-19 when exposed to Violeds photons for 30 seconds. The study also finds the coronavirus becomes even more sterile when placed closer to the photon with longer exposure time. In addition to testing the coronavirus, the Violeds technology also proved to be successful in sterilizing 99.9% of other harmful bacteria such as Escherichia coli, Staphylococcus Aureus, Pseudomonas Aeruginosa, Klebsiella Pneumoniae, and Salmonella Typhimurium.

Violeds, compound semiconductor technology, is the brand name of technology that utilizes UV LED for sterilization and deodorization functions. This concept clean technology has been developed by Seoul Viosys with SETi since 2005 to prevent germ proliferation through the use of a light source (photon) without the need of chemicals that could be harmful to humans. Violeds technology, which has been recognized for its excellent sterilization and stability, has also been used to clean environments for astronauts at NASA’s space station in the United States. Until now, general commercial applications have been limited, as their lifetime was too short for prolonged use. However, since 2019, new patented technology has extended the previous life span by 50,000 hours, making it now the optimal solution for air purification and water sterilization products.

Seoul Semiconductor, Seoul Viosys of South Korea, and SETi Inc. of the United States, focuses solely on compound semiconductors. The company holds more than 14,000 patents, in addition to spending over $100 million a year on research and development. CEO Chung Hoon Lee, who is son of farmer himself, said when Jimmy Carter, the son of a farmer, became the president of the United States, it has become a turning point in life. He expressed “new history in the light” and “I hope this success story will be a small but heart-breaking story for small and medium-sized manufacturing companies and young start-ups who are dreaming of manufacturing”.

About Seoul Viosys

Seoul Viosys is a full-line solution provider for UV LED, VCSEL (Vertical Cavity Surface Emitting Laser), the next-generation light source for 3D sensor and laser, and single-pixel RGB “Micro Clean Pixel” for displays. Established in 2002 as a subsidiary of Seoul Semiconductor, it captured No. 1 market share in the UV LED industry (LEDinside, 2018). Seoul Viosys has an extensive UV LED portfolio with all wavelengths range (200nm to 1600nm) including ultraviolet rays (UV), visible rays and infrared rays. It holds more than 4,000 patents related to UV LED technology. Violeds, its flagship UV LED technology, provides a wide range of industries with optimal solutions for strong sterilization and disinfection (UVC), skin regeneration (UVB), water/air purification and effective cultivation for horticulture. In 2018, Seoul Viosys acquired RayCan, a leading optoelectronic specialist, to add the advanced VCSEL technology which supports smartphone facial recognition and autonomous driving, and has started its mass production. In January 2020, it introduced disruptive “Micro Clean Pixel” that has potential to be game-changer in the display market. To learn more, visit http://www.seoulviosys.com/en/.

About SETi

Sensor Electronic Technology, inc. (SETi), a division of Seoul Semiconductor and Seoul Viosys, is a company based in Columbia, South Carolina, founded in 1999 by four Ph.D., for research and development of compound semiconductors in the United States. In 2005, SETi received the investment and R&D fund from Seoul Semiconductor and Seoul Viosys. For the development project, SETi is also working with the University of South Carolina and the University of California at Santa Barbara, adding depth to its research and development.
Currently, SETi is the only company in the world that can produce UV LEDs from 200nm to 430nm. To learn more, visit http://www.s-et.com/en/.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media Contacts:
Seoul Semiconductor Co., Ltd.
Jeonghee Kim
Tel: +82-70-4391-8311
Email: jeonghee.kim@seoulsemicon.com

North America
Andrew Smith
Tel: (901) 831-6614
Email: andrew.smith@seoulsemicon.com

Sales Contacts:
Americas
Mike Berens
mberens@s-et.com

Asia
Dong Ju Kim
djkim@seoulviosys.com

Europe
Marko Hofmann
marko.hofmann@seoulviosys.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Align Partners Sends Second Public Shareholder Letter to Coway, Urging Announcement of Revised Value-up Plan by January 30, 202615.12.2025 15:54:00 CET | Press Release

Align Partners Capital Management Inc. (“Align Partners”), a shareholder of Coway Co., Ltd. (“Coway”) since 2023 holding more than 4% of the Company’s outstanding shares through funds it manages or advises, announced that it has sent a second public shareholder letter to Coway’s Board of Directors. The letter calls for measures to address the company’s chronic undervaluation and enhance shareholder value. Align Partners has requested that Coway announce a revised corporate Value-up Plan reflecting these proposals by January 30, 2026. In the letter, Align Partners assessed Coway’s February 2025 plan as insufficient to address Coway’s persistent undervaluation and urged the Board to incorporate seven measures: (1) clear mid-to-long-term valuation and ROE targets with execution plans; (2) clarified and strengthened target capital structure policy; (3) updated shareholder return policy reflecting both the target capital structure policy and new dividend income tax separation regime; (4) en

Marathon Asset Management Provides Junior Capital Financing to EXALTA Group15.12.2025 15:00:00 CET | Press Release

Marathon Asset Management (“Marathon”), a leading global credit manager with more than $24 billion of assets under management, is pleased to announce the closing of a junior capital financing to EXALTA Group (“EXALTA” or the “Company”), a portfolio company of Montagu. Marathon led the financing that supported the formation of EXALTA through the strategic merger of three Montagu-owned companies including Intech, Resolve Surgical Technologies, and Tyber Medical. The transaction marks one of many successful transactions for Marathon’s European Credit business in the healthcare sector, where the firm has a knowledge-based advantage with a dedicated Healthcare Finance business and specialized medical advisory board providing sector insight to middle market companies. EXALTA is a global leader in orthopaedic contract design and manufacturing for spine, trauma, extremities, sports medicine and enabling technology providing comprehensive solutions to OEMs within the medical technology industry

Aurobay Technologies Expands Digital Transformation Partnership With HCLTech to Boost Manufacturing Excellence and Innovation15.12.2025 14:29:00 CET | Press Release

HCLTech, a leading global technology company, and Aurobay Technologies, a division of Horse Powertrain and a global leader in hybrid and low-emission powertrain solutions, have expanded their digital transformation partnership to support Aurobay’s global growth strategy. The expanded partnership establishes HCLTech as Aurobay Technologies’ trusted partner for managing and optimizing SAP, Siemens Teamcenter PLM software and integration services in Sweden and China. This will unlock cost efficiency, operational resilience and digital innovation across Aurobay’s manufacturing and engineering functions by leveraging HCLTech’s flagship service transformation platform, AI Force. The engagement spans core business functions including SAP operations, engineering systems, integration services and mainframe environments, reinforcing Aurobay’s focus on scale, efficiency and seamless operations across global locations. “Horse Powertrain’s division Aurobay Technologies’ digital transformation conti

Applications Now Open for the 5th Cycle of the Mohammed bin Rashid Al Maktoum Global Water Award15.12.2025 14:28:00 CET | Press Release

HE Saeed Mohammed Al Tayer, Chairman of the Board of Trustees of the UAE Water Aid Foundation (Suqia UAE), announced the opening of applications for the 5th cycle of the Mohammed bin Rashid Al Maktoum Global Water Award, offering USD 1 million in prizes. The award seeks to inspire innovative, clean energy–powered solutions for water production, distribution, storage, desalination and purification, supporting global sustainability efforts. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215897854/en/ HE Saeed Mohammed Al Tayer, Chairman of the Board of Trustees of the UAE Water Aid Foundation (Suqia UAE) - (Photo: AETOSWire) “Since its establishment, Suqia UAE, launched by His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, has provided clean water to nearly 15 million people in 37 countries worldwide through sustainable development and humanitarian projects.

Novotech Issues White Paper to Help Sponsors Strengthen Early-Phase Oncology Strategy and Execution15.12.2025 14:05:00 CET | Press Release

Novotech, a leading global full-service clinical research organization (CRO) and scientific advisory company, has released a new white paper, Early-Phase Oncology – Clinical Research Landscape and CRO Enablers (2025), offering in-depth analysis of the key drivers shaping early-phase oncology development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215843975/en/ With approximately 60% of oncology agents progressing from Phase I to Phase II, but only 3–6% reaching regulatory approval, the paper outlines the factors influencing early-stage success, including trial design, patient selection, and regional development pathways. The paper highlights Australia’s continued position as a global first-in-human (FIH) and early-phase research hub. Its ethics-led review frameworks, which can support trial initiation within roughly 4–8 weeks, combined with established FIH centers, oncology networks, and cost efficiencies, position Au

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye